PHARMACOLOGY OF THE HIV VIRAL DNA AND RETROVIRAL INTEGRASES
PHARMACOLOGY OF THE HIV VIRAL DNA AND RETROVIRAL INTEGRASES
批准号:
2463724
负责人:
Y POMMIER
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
DNA replication DNA topoisomerases antiAIDS agent chemical binding drug interactions drug screening /evaluation enzyme inhibitors enzyme mechanism enzyme structure human immunodeficiency virus 1 integrase intermolecular interaction protein structure function virus DNA virus genetics virus infection mechanism virus integration virus protein
中文摘要
为了进一步扩大发展目标的数量,
抗逆转录病毒药物,我们正在研究潜在的艾滋病毒整合酶
使用体外整合酶测定的抑制剂。 将活性化合物
提交用于测试其在NCI抗HIV药物中的抗病毒活性
屏幕 相反,我们正在测试屏幕上的活性化合物,
用于HIV 1整合酶抑制。
药物与HIV 1整合酶的分子相互作用是
通过使用几种测定法比较药物效果进行研究
探索整合反应的不同步骤:1)DNA结合,
2)二核苷酸切割和攻击亲核试剂的差别使用
(水,3 ′-DNA末端,甘油),3)链转移(整合),
4)野生型的解体(整合反应的逆转)
和截短的HIV 1整合酶。 我们的目标是发现新的抗病毒药物
药物,以确定活性药物的药物筛选是否会导致
整合酶抑制剂的发现,以评估哪一步,
整合反应可被药物抑制(酶寡聚化,
DNA结合、3 '加工、DNA链转移、解体),以及
以确定HIV 1整合酶中的药物结合位点。 为了
为了验证一些抑制剂会干扰
选择性地与酶的特定功能结构域(锌
指,催化区,DNA结合域),遗传改变的HIV 1
使用整合酶。HIV整合酶抑制剂的发现可能提供
抗逆转录病毒疗法的新战略和
药物-酶相互作用
在过去的一年里,我们继续研究核苷酸
抑制剂,并确定了一系列的二核苷酸活性的uM
范围和水溶性。 核苷酸作为先导化合物具有吸引力
用于共结晶研究。 我们还发现鸟苷
四重衍生物在纳摩尔浓度下具有活性,
抗病毒活性。 在药物化学家的合作下,我们
我们继续从CAPE衍生物的结构活性研究
并从活性化合物中鉴定出新型抑制剂
NCI的屏幕。最后,开发了一种新的检测方法来监测
整合酶-DNA结合,可用于进一步研究
酶-DNA相互作用和抑制剂的作用。
英文摘要
In an effort to further extend the number of targets for development
of antiretroviral agents, we are investigating potential HIV integrase
inhibitors using in vitro integrase assays. The active compounds are
submitted for testing their antiviral activity in the NCI Anti-HIV Drug
Screen. Conversely, we are testing active compounds from the screen
for HIV1 integrase inhibition.
The molecular interactions of drugs with the HIV1 integrase are
investigated by comparing the drugs effects using several assays
exploring different steps of the integration reaction: 1) DNA binding,
2) dinucleotide cleavage and differential use of attacking nucleophiles
(water, 3'-DNA terminus, glycerol), 3) strand transfer (integration),
4) dis-integration (reverse of the integration reaction) by wild-type
and truncated HIV1 integrases. Our goals are to discover new antiviral
agents, to determine whether drug screening of active agents will lead
to the discovery of integrase inhibitors, to evaluate which step of the
integration reaction can be inhibited by drugs (enzyme oligomerization,
DNA binding, 3'processing, DNA strand transfer, disintegration), and
to determine the drug binding site(s) in the HIV1 integrase. In order
to test the hypothesis that some of the inhibitors interfere
selectively with a specific functional domain of the enzyme (zinc
finger, catalytic region, DNA binding domain), genetically altered HIV1
integrases are used. Discovery of HIV integrase inhibitors may provide
new strategies for antiretroviral therapy and basic knowledge for
drug-enzyme interactions.
During the past year, we have continued our studies with nucleotide
inhibitors and identified a series of dinucleotides active in the uM
range and water-soluble. Nucleotides are attractive as lead compounds
for co-crystallization studies. We have also shown that guanosine
quartet derivatives are active at nanomolar concentrations and exhibit
antiviral activity. In collaboration with the medicinal chemists, we
have continued our structure-activity studies from CAPE derivatives
and identified novel classes of inhibitors from the active compounds
of the NCI screen. Finally, a novel assay has been developed to monitor
integrase-DNA binding, that can be used to further investigate the
enzyme-DNA interactions and the effects of inhibitors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:3752315
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:3916548
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
TOPOISOMERASE II AS TARGET OF ACTION OF ANTICANCER DRUG
-
批准号:3939497
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PHARMACOLOGY OF THE HIV VIRAL DNA
-
批准号:3838171
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:3853153
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:2463710
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:3838030
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:3752316
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:3774547
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:2463709
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:3874383
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
STUDIES OF TOPOISOMERASE II AS TARGET OF ACTION OF ANTICANCER DRUG
-
批准号:3963209
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA STRAND BREAKS AS INDICATOR OF TOPOI
-
批准号:4692081
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
STUDIES OF TOPOISOMERASE II AS TARGET OF ACTION OF ANTICANCER DRUG
-
批准号:4692083
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PHARMACOLOGY OF THE HIV VIRAL DNA AND RETROVIRAL INTEGRASES
-
批准号:6100896
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:3774548
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:6160983
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:3916549
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:5201240
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PHARMACOLOGY OF THE HIV VIRAL DNA
-
批准号:5201355
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
海外基金